Neoadjuvant systemic therapy utilization in breast cancer; potential impact on nodal radiotherapy

被引：0
|
作者：
Beecham, K. [1 ]
Olson, R. [1 ]
Tyldesley, S. [2 ]
Speers, C. [3 ]
Simmons, C. [4 ]
Cheifitz, R. [5 ]
Sutter, M. [6 ]
Voduc, D. [2 ]
机构：
[1] British Columbia Canc Agcy, Radiat Oncol, Prince George, BC, Canada
[2] British Columbia Canc Agcy, Radiat Oncol, Vancouver, BC, Canada
[3] British Columbia Canc Agcy, Outcomes Unit, Vancouver, BC, Canada
[4] British Columbia Canc Agcy, Med Oncol, Vancouver, BC, Canada
[5] British Columbia Canc Agcy, Surg, Vancouver, BC, Canada
[6] British Columbia Canc Agcy, Surg, Prince George, BC, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1186
引用
收藏
页码：S643 / S644
页数：2
相关论文
共 50 条
  • [31] Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?
    Eniu, A.
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2008, 1 (03) : 143 - 147
  • [32] Mammographic density to predict response to neoadjuvant systemic breast cancer therapy
    S. Di Cosimo
    C. Depretto
    R. Miceli
    P. Baili
    S. Ljevar
    M. Sant
    V. Cappelletti
    S. Folli
    M. Gennaro
    F. G. De Braud
    G. Bianchi
    A. Vingiani
    G. Pruneri
    A. Marchianò
    E. La Rocca
    M. C. De Santis
    G. P. Scaperrotta
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 775 - 781
  • [33] Surgical considerations for breast cancer patients receiving neoadjuvant systemic therapy
    Hunt, Kelly K.
    Mittendorf, Elizabeth A.
    [J]. BREAST CANCER MANAGEMENT, 2013, 2 (05) : 385 - 395
  • [34] Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy
    Zahraa Al-Hilli
    Grace Choong
    Michael G. Keeney
    Daniel W. Visscher
    James N. Ingle
    Matthew P. Goetz
    James W. Jakub
    [J]. Breast Cancer Research and Treatment, 2019, 176 : 709 - 716
  • [35] Controversies Concerning the Use of Neoadjuvant Systemic Therapy for Primary Breast Cancer
    Manfred Kaufmann
    Thomas Karn
    Eugen Ruckhäberle
    [J]. World Journal of Surgery, 2012, 36 : 1480 - 1485
  • [36] The impact of neoadjuvant systemic treatment on postoperative complications in breast cancer surgery
    Nussbaumer, R. L.
    Maggi, N.
    Castrezana, L.
    Zehnpfennig, L.
    Schwab, F. D.
    Krol, J.
    Oberhauser, I
    Weber, W. P.
    Kurzeder, C.
    Haug, M. D.
    Kappos, Elisabeth A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2023, 197 (02) : 333 - 341
  • [37] Sometimes a great notion - An assessment of neoadjuvant systemic therapy for breast cancer
    Davidson, NE
    Morrow, M
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (03) : 159 - 161
  • [38] Neoadjuvant Chemotherapy for Operable Breast Cancer: Individualizing Locoregional and Systemic Therapy
    Bear, Harry D.
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (03) : 607 - +
  • [39] Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy
    Al-Hilli, Zahraa
    Choong, Grace
    Keeney, Michael G.
    Visscher, Daniel W.
    Ingle, James N.
    Goetz, Matthew P.
    Jakub, James W.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (03) : 709 - 716
  • [40] Mammographic density to predict response to neoadjuvant systemic breast cancer therapy
    Di Cosimo, S.
    Depretto, C.
    Miceli, R.
    Baili, P.
    Ljevar, S.
    Sant, M.
    Cappelletti, V
    Folli, S.
    Gennaro, M.
    De Braud, F. G.
    Bianchi, G.
    Vingiani, A.
    Pruneri, G.
    Marchiano, A.
    La Rocca, E.
    De Santis, M. C.
    Scaperrotta, G. P.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (04) : 775 - 781
12345